Susan S. Smyth

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

20 h-index 78 pubs 1,722 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Susan S. Smyth's research focuses on identifying and understanding biomarkers related to thrombotic risk, particularly in the context of COVID-19. She has investigated the role of von Willebrand factor and extracellular vesicles in COVID-19-associated thrombosis and contributed to a consensus statement on novel biomarkers for this condition. Her work also explores the mechanisms by which extracellular histones can trigger disseminated intravascular coagulation through lytic cell death.

Beyond thrombotic events, Smyth's research interests extend to clinical practice implementation and patient experiences. She has examined the planning and success factors for implementing syncope clinical practice guidelines in emergency departments, drawing on frameworks like CFIR. Additionally, she has explored patient expectations for syncope evaluation and management.

Smyth's scholarship includes studies on occupational health, specifically examining menopause in the workplace through an organization-based case study. She also contributes to the field of health sciences research education, investigating KL2 scholars' perceptions of factors contributing to sustained translational science career success. Her work has resulted in 78 publications and garnered 1,722 citations, with an h-index of 20. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Jerry Ware and Nishank Jain, and leads a research group.

Metrics

  • h-index: 20
  • Publications: 78
  • Citations: 1,722

Selected Publications

  • Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides (2024) DOI
  • 438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease (2023) DOI
  • Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department (2023) DOI
  • Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023) DOI
  • Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death (2022) DOI
  • Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death (2022) DOI
  • Bioactive lipids and metabolic syndrome—a symposium report (2022) DOI
  • Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022) DOI
  • KL2 scholars’ perceptions of factors contributing to sustained translational science career success (2021) DOI
  • Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool (2021) DOI
  • COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics